Bioequivalence study of donepezil orally disintegrating tablet and conventional tablet based on multivariate multilevel model

Pei-ran CHEN,Zhong-ping GOU,Rong TANG,Li-hong XIAO,Xin-xing ZHANG,Ping FENG
DOI: https://doi.org/10.14109/j.cnki.xyylc.2017.06.012
2017-01-01
Abstract:AIM To evaluate the bioequivalence between donepezil orally disintegrating tablet and donepezil conventional tablet by the multivariate multilevel model.METHODS Twenty-two healthy volunteers were enrolled in the study and they orally took donepezil orally disintegrating tablet (the test) 5 mg or donepezil conventional tablet (the reference) 5 mg.HPLC-MS/MS was used to determine the plasma concentration of donepezil at different time points after drug administration.The evaluation of the bioequivalence was carried out by gradually establishing the models.First,the zero models were established to explore the clustering effect of data at period level or individual level,and then the multilevel models were set up.The multivariate multilevel model was finally established as ρmax and AUC0-t were correlated.RESULTS The random effects of the multivariate multilevel model were significantly different (P < 0.05).ρmax and AUC0-t were strongly correlated.The fixed effect of ρmax and AUC0-t in the model indicated the difference between the test and the reference was insignificant,and their joint confidence interval was ranged from-0.020 to-0.007.CONCLUSION The multivariate multilevel model can explain the variation and shrink the confidence interval.Donepezil orally disintegrating tablet shows a bioequivalence compared with the reference.
What problem does this paper attempt to address?